The Board of Directors of Liaoning Chengda Biotechnology Co.,Ltd. has authorized a buyback plan on March 11, 2024.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
27.29 CNY | +0.59% | -0.58% | -16.06% |
May. 20 | Wall Street Cues, Central Bank Outlooks Lift Asian Stock Markets | MT |
Apr. 29 | Liaoning Chengda Biotechnology Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-16.06% | 1.56B | |
-1.85% | 89.87B | |
-3.95% | 37.57B | |
+61.98% | 26.47B | |
-22.14% | 14.25B | |
-7.96% | 12.99B | |
-9.33% | 11.93B | |
-46.33% | 10.84B | |
+5.24% | 9.11B | |
-19.53% | 7.32B |
- Stock Market
- Equities
- 688739 Stock
- News Liaoning Chengda Biotechnology Co.,Ltd.
- Liaoning Chengda Biotechnology Co.,Ltd. authorizes a Buyback Plan.